STAT5B and invasive breast carcinoma: Tumor levels of Stat5a and Stat5b mRNA in a cohort of 936 patients with available outcome data were then interrogated to determine whether expression of Stat5a or Stat5b in primary invasive breast cancer was associated with clinical outcome.